kabutan

PeptiDream Inc.(4587) Summary

4587
TSE Prime
PeptiDream Inc.
1,169.5
JPY
-15.5
(-1.31%)
Apr 28, 3:30 pm JST
7.34
USD
Apr 28, 2:30 am EDT
Result
PTS
outside of trading hours
1,165
Apr 28, 11:29 pm JST
Summary Chart Historical News Financial Result
PER
50.3
PBR
2.93
Yield
ー%
Margin Trading Ratio
8.94
Stock Price
Apr 28, 2026
Opening Apr 28, 9:00 am
1,188.0 JPY 7.45 USD
Previous Close Apr 27
1,185.0 JPY 7.43 USD
High Apr 28, 9:00 am
1,197.5 JPY 7.51 USD
Low Apr 28, 3:01 pm
1,165.5 JPY 7.31 USD
Volume
833,500
Trading Value
0.98B JPY 6.14M USD
VWAP
1173.61 JPY 7.37 USD
Minimum Trading Value
116,950 JPY 734 USD
Market Cap
0.15T JPY 0.96B USD
Number of Trades
2,023
Liquidity & Number of Trades
As of Apr 28, 2026
Liquidity
High
1-Year Average
2,628
1-Year High Dec 3, 2025
9,661
Margin Trading
Date Short Interest Long Margin Positions Ratio
Apr 24, 2026 165,500 2,745,600 16.59
Apr 17, 2026 148,700 2,577,500 17.33
Apr 10, 2026 158,300 2,464,700 15.57
Apr 3, 2026 149,200 2,424,200 16.25
Mar 27, 2026 155,600 2,692,600 17.30
Company Profile
PeptiDream Inc. is a drug discovery venture company that collaborates with major pharmaceutical companies to develop peptide-based drugs. The company has also acquired a radiopharmaceutical business.
Sector
Pharmaceuticals
PeptiDream Inc. is a biotech venture originating from the University of Tokyo, focusing primarily on drug discovery and development using special peptides through its proprietary drug discovery platform system, PDPS. The company engages in collaborative drug research and development using PDPS, technology licensing, and strategic partnerships to expand its in-house pipeline. Through its subsidiary PDR Pharma, PeptiDream Inc. also operates in the radiopharmaceutical business, conducting research, development, manufacturing, and sales of diagnostic and therapeutic radiopharmaceuticals. The company concentrates on developing diagnostic agents for imaging cancer and abnormal brain accumulations, as well as therapeutic radiopharmaceuticals targeting unmet medical needs, particularly in the field of oncology. As a group, PeptiDream Inc. operates across a wide range of areas including research, development, manufacturing, and sales of pharmaceuticals and related products.